Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)

Historical Holders from Q2 2021 to Q2 2025

Symbol
ANEB on Nasdaq
CUSIP
034569103
Type / Class
Equity / Common Stock
Shares outstanding
41.1M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
22.6M
Holdings value
$32.5M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
18
Number of buys
8
Number of sells
-5
Average Value change %
0%
Average buys %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
English Aron R. 51.1% 0% $21.1M 21.9M 0% Aron R. English Feb 24, 2025
Nantahala Capital Management, LLC 8.63% $3.41M 3.55M Nantahala Capital Management, LLC Dec 31, 2024
MANGROVE PARTNERS IM, LLC 6.15% $2.42M 2.53M Mangrove Partners IM, LLC Dec 31, 2024

Institutional Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 22.6M $32.5M -$34.5K $1.44 18
2025 Q1 22.6M $29.4M +$39.5K $1.30 18
2024 Q4 22.6M $37.3M +$25M $1.68 15
2024 Q3 7.34M $14.2M +$69.1K $1.93 13
2024 Q2 7.31M $20M +$324 $2.73 12
2024 Q1 7.31M $21M +$85.9K $2.87 14
2023 Q4 7.28M $17.6M +$437K $2.42 13
2023 Q3 7.05M $21.6M +$51.8K $3.06 11
2023 Q2 7.03M $16.5M +$460K $2.35 11
2023 Q1 6.84M $19.8M -$72.5K $2.90 9
2022 Q4 7.05M $17.1M -$16K $2.42 12
2022 Q3 6.84M $19.2M +$6.06M $2.80 10
2022 Q2 4.68M $24.3M +$2.19M $5.20 8
2022 Q1 4.19M $29.5M +$36.9K $7.02 8
2021 Q4 4.19M $25.8M +$61.8K $6.21 8
2021 Q3 4.18M $27.5M -$109K $6.58 7
2021 Q2 4.2M $28.7M +$28.7M $6.85 8